MARATTO

article · International Journal of Medical Sciences and Pharma Research

Co-expression of Extensively drug resistant (XDR) clinical isolates of Pseudomonas aeruginosa harboring FOX and MOX ampicillinase Gene

20231 citationOpen accessThe Federal Polytechnic, Ado-Ekiti

Abstract

This study determines the Co-expression of clinical isolates of XDR Pseudomonas aeruginosa harboring FOX and MOX ampicillinase Gene. A total of five (500) hundred “Clean catch” midstream urine and wound samples collected from patients at a tertiary healthcare institution in Ebonyi State Nigeria were analyzed using standard microbiological techniques. Determination of XDR Pseudomonas aeruginosa isolates was by Kirby-Bauer disc diffusion method. Molecular characterization of FOX and MOX ampicillinase resistant genes were done by PCR using specific primers. In total, the Pseudomonas aeruginosa accounted for 22.6 %. XDR Pseudomonas aeruginosa accounted for 17. 8 % and 25.3 % in Wound and urine samples respectively. All the XDR Pseudomonas aeruginosa harbored FOX and MOX ampicillinase resistant Gene. The high frequency of XDR Pseudomonas aeruginosa in our study is very worrisome and could have significant public health impact such as treatment failures, and possibly death, if not properly managed. The solutions to this crisis are to allocate more resources to basic and clinical research and to infection control and antimicrobial stewardship, to develop new antimicrobials, and to optimize the use of those that are currently available. Keywords: XDR, Pseudomonas aeruginosa, FOX, MOX ampicillinase

Research topics

  • Antibiotic Resistance in Bacteria
  • Antibiotic Use and Resistance
  • Vibrio bacteria research studies

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.22270/ijmspr.v9i3.76

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.